A carregar...

Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks

OBJECTIVE: To identify factors predicting response (2‐hour headache pain freedom or most bothersome symptom freedom) to lasmiditan based on individual patient characteristics, migraine disease characteristics, and migraine attack characteristics. Further, efficacy specifically in difficult‐to‐treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Headache
Main Authors: Tepper, Stewart J., Vasudeva, Raghavendra, Krege, John H., Rathmann, Suchitrita S., Doty, Erin, Vargas, Bert B., Magis, Delphine, Komori, Mika
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496706/
https://ncbi.nlm.nih.gov/pubmed/32634275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!